EMIG Logo

Network

Network

The EMIG Network includes approximately 1,500 individuals from Member companies and organisations, ranging from pharma companies to Associate Members offering vital services. Our membership also extends to patient charities, research organisations, and universities, all of which benefit from free membership.

Members can access collective expertise through our 'Network Questions' service. This allows any member to anonymously submit a question or request assistance via our web portal, with responses made freely available in the members' area.

  • We are developing a clinical decision-support tool that flags potential risk for rare or underdiagnosed conditions but does not provide diagnostic conclusions.

  • SystemOne

  • We are exploring the feasibility of repackaging a P product that is currently sold in multi-dose quantities into single-use packs.

  • Our company is considering not waiting for CHMP positive opinion for a line extension application want to apply to the MHRA for the line extension application via a T2V

  • My son is completing an MSc in Neuroscience next year in Berlin having studied for his BSc in Manchester in same subject.

  • I am looking for a recommendation for an accountant to work with a small UK Pharma start-up.

  • Does anyone have experience distributing patient risk management materials outside of emc and Medical Info teams?

  • Can anyone share examples of how to ensure patient alert cards get to patients when using an infusion cancer drug

  • Does anyone have experience with withdrawing a simple Patient Access Scheme (PAS)?

  • Can anyone recommend a provider of injector fat pad training devices?

  • Looking for a provider of medical training aids.

  • We are experiencing challenges with Boots online stock checker

  • Industrial placement year needed.

  • Is anyone aware if you can set maximum selling prices to patients for products that are prescribed privately such that patients are not over charged?

  • We are looking to understand member experiences of companies prepared for launching their first asset:

  • We are looking for a single platform that is suitable for both PV and Med Info requirements, and wondered if anyone can recommend a validated system?

  • We are looking to review our bonus scheme, and I would be grateful for your assistance please!

  • Does anyone have experience of NICE not selecting any of the company-nominated clinical experts?

  • I see the regulatory experts often debating on whether a particular product is suitable to be used as a “Reference product” for a generic filing to MHRA.

  • Can anyone recommend a consultant with experience in listing OTC medical devices on Amazon UK (FBA selling model)?

  • We are doing more business selling our products in India.

  • I am one of the last people in our meetings to have a physical business card.

  • I am helping an organisation looking at their internship programme(s) for next year and would value input please.

  • We are planning a Day 1 generic launch in the UK. The product is currently protected solely by an SPC.

  • We are launching an ERT that requires fridge storage. We have been asked by hospitals to provide patients with a fridge to store drug for self administration at home.